Delivery Order SPE2DB24D9131-SPE2DB25FXRV2
- Not listed
- The Defense Logistics Agency awarded a $2,783.55 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of August 12, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The place of performance is listed as Park Ridge, IL 60068, and the delivery order represents pharmaceutical supply to support federal healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $5,567.10 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of November 4, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order represents a firm fixed-price contract type, with performance to be completed at the awardee's Park Ridge facility. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of June 3, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the delivery at its facility in Park Ridge, IL. This delivery order utilizes firm fixed-price pricing and was issued without a set-aside designation, allowing the contractor to compete...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,161.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of YF-VAX 1 dose vials, with a completion date of September 7, 2021. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs through...
- The Defense Logistics Agency awarded a delivery order valued at $22,268.40 to DMS Pharmaceutical Group Inc. on August 26, 2025, for the supply of YF-VAX 1 Dose Vials. This firm fixed-price delivery order is scheduled for completion by September 17, 2025, with performance taking place in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois, was selected without a set-aside designation. The company leverages its established...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,113.42 by the Defense Logistics Agency (DLA) on September 2, 2025, for YF-VAX 1 dose vials. The award is a firm fixed-price delivery order with no set-aside designation, reflecting the company's competitive standing in federal pharmaceutical procurement. Performance is scheduled for completion by September 23, 2025, at the contractor's...
- The Defense Logistics Agency awarded a $1,113.42 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of August 11, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge. This delivery order was issued without a set-aside designation, allowing the vendor to compete in the open market while leveraging its...
- The Defense Logistics Agency awarded a delivery order valued at $2,783.55 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of August 4, 2025. The award was announced on July 14, 2025, under a firm fixed-price contract type with no set-aside designation. Performance will take place in Park Ridge, Illinois, where the woman-owned small business contractor is based. DMS Pharmaceutical Group Inc. is a long-established pharmaceutical wholesaler registered in...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of July 25, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The contract is structured as a firm fixed-price delivery order, reflecting the established pricing for this specific pharmaceutical product within the...
- On August 12, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its Park Ridge facility. The contract utilizes a firm fixed-price structure with an ultimate completion date of September 3, 2025, and no set-aside designation was applied to this award....
- SPE2DB24D9131Indefinite Delivery Contract
- SPE2DB24D9131-SPE2DB25FXRV2Delivery Order
The Defense Logistics Agency awarded a $2,783.55 delivery order to DMS Pharmaceutical Group Inc. on September 16, 2025, for YF-VAX 1 Dose Vials with an ultimate completion date of October 7, 2025. This firm fixed-price delivery order carries no set-aside designation and is to be performed in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, serves as the prime contractor and has been registered in the System for Award Management since 2001. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The IDC enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has demonstrated consistent success in securing federal pharmaceutical contracts across diverse product categories, positioning the company as a critical supplier within the federal pharmaceutical supply chain for military health system requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 9/16/25 |